Allogene Therapeutics (ALLO) vs Electra Therapeutics (ETRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Electra Therapeutics is the larger company by market cap ($574.9 million vs $494.1 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ALLO | ETRA |
|---|---|---|
| Share price | $1.43 | $9.16 |
| Market cap | $494.05M | $574.95M |
| 1-day change | -2.05% | -6.72% |
| EPS (TTM) | $-0.66 | $-2.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.46 | $15.50 |
| 52-week low | $1.04 | $8.92 |
| Distance from 52-week high | -67.94% | -40.90% |
| Average volume | 5.78M | 990.55K |
| Shares outstanding | 345.49M | 62.77M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ALLO vs ETRA FAQ
Which is bigger, Allogene Therapeutics or Electra Therapeutics?
Electra Therapeutics (ETRA) is larger, with a market capitalization of $574.95M compared with $494.05M for Allogene Therapeutics (ALLO).
Are Allogene Therapeutics and Electra Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.